Product
CD19 CAR T-Cell
1 clinical trial
3 indications
Indication
B-cell Acute Lymphoblastic LeukemiaIndication
B-cell lymphomaIndication
UnspecifiedClinical trial
Humanized CAR19T2 T Cell in Children With Refractory/Relapsed B-cell Leukemia/LymphomaStatus: Withdrawn, Estimated PCD: 2025-12-01